CStone Pharmaceuticals Stock Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
17:25:01 06/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.6404 EUR | +2.60% |
|
+15.10% | +12.35% |
| 09-24 | CStone Pharma CEO Buys HK$2.7 Million of Shares | MT |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| Market Cap | 7.95B 1.19B 1.05B 987M 894M 1.69B 115B 1.7B 11.86B 4.6B 58.38B 4.46B 4.37B 188B | P/E 2026 * |
-17.2x | P/E 2027 * | 4.67x |
|---|---|---|---|---|---|
| Enterprise Value | 6.98B 1.04B 924M 866M 784M 1.48B 100B 1.49B 10.4B 4.04B 51.2B 3.91B 3.83B 165B | EV / Sales 2026 * |
16.5x | EV / Sales 2027 * | 2.28x |
| Free-Float |
79.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript: CStone Pharmaceuticals
| 1 day | +2.60% | ||
| 1 week | +15.10% | ||
| Current month | +0.06% | ||
| 1 month | -14.04% | ||
| 3 months | +6.77% | ||
| 6 months | -36.59% | ||
| Current year | +12.35% |
| 1 week | 0.62 |  | 0.66 |
| 1 month | 0.55 | | 0.67 |
| Current year | 0.45 | | 1.12 |
| 1 year | 0.45 | | 1.12 |
| 3 years | 0.09 | | 1.35 |
| 5 years | 0.09 | | 1.35 |
| 10 years | 0.09 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.60% | +15.10% | - | - | 1.15B | |
| +1.26% | -2.30% | +37.82% | +113.76% | 1,019B | |
| +0.73% | -6.31% | +35.06% | +62.14% | 610B | |
| +0.35% | +0.15% | +14.01% | +80.87% | 470B | |
| +1.72% | -4.54% | +59.14% | +37.01% | 344B | |
| +0.26% | -1.58% | +21.97% | +41.79% | 336B | |
| +0.60% | -3.48% | +11.37% | +34.33% | 266B | |
| +1.65% | -4.27% | -5.47% | +9.69% | 241B | |
| -0.09% | -3.71% | +35.15% | +51.88% | 218B | |
| -0.28% | -5.24% | +27.99% | +93.08% | 179B | |
| Average | +0.63% | -3.63% | +26.34% | +58.28% | 409.2B | |
| Weighted average by Cap. | +0.32% | -3.51% | +29.49% | +70.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 63.23M 56.06M 52.51M 47.55M 89.68M 6.09B 90.61M 631M 245M 3.11B 237M 232M 10B | 1.72B 257M 228M 214M 194M 365M 24.8B 369M 2.57B 997M 12.64B 966M 945M 40.71B |
| Net income | -384M -57.32M -50.81M -47.59M -43.1M -81.29M -5.52B -82.13M -572M -222M -2.81B -215M -211M -9.07B | 680M 102M 90.15M 84.44M 76.46M 144M 9.8B 146M 1.01B 394M 4.99B 382M 373M 16.08B |
| Net Debt | -978M -146M -130M -121M -110M -207M -14.08B -209M -1.46B -566M -7.17B -548M -537M -23.11B | -4.02B -601M -533M -499M -452M -853M -57.93B -861M -6B -2.33B -29.52B -2.26B -2.21B -95.09B |
| Date | Price | Change |
|---|---|---|
| 06/10/26 | €0.6404 | +2.60% |
| 05/10/26 | €0.6242 | +0.42% |
| 02/10/26 | €0.6216 | -2.63% |
| 01/10/26 | €0.6384 | -0.25% |
| 30/09/26 | €0.6400 | +4.85% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions
